Preimplantation Genetic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Procedure (Pre-implantation genetic diagnosis (PDS), Preimplantation Genetic Screening (PGS)) By Product (Reagents and Consumables, Instruments, Software), By Technology (Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH), Ot
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationPreimplantation Genetic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Procedure (Pre-implantation genetic diagnosis (PDS), Preimplantation Genetic Screening (PGS)) By Product (Reagents and Consumables, Instruments, Software), By Technology (Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH), Ot
| Forecast Period | 2024-2028 |
| Market Size (2022) | USD 557.28 million |
| CAGR (2023-2028) | 8.22% |
| Fastest Growing Segment | Pre-implantation genetic diagnosis PGD segment |
| Largest Market | Europe |
Market Overview
Global Preimplantation Genetic Testing Market has valued at USD 557.28 million in 2022 and is anticipated to project robust growth in the forecast period with a CAGR of 8.22% through 2028. Preimplantation Genetic Testing is a medical procedure used in assisted reproductive technology (ART) to screen embryos for genetic abnormalities before they are implanted into the uterus. It is primarily employed during in vitro fertilization (IVF) treatments to increase the chances of a successful pregnancy and reduce the risk of passing on certain genetic disorders to the child. There are two main types of preimplantation genetic testingPGT-A (Preimplantation Genetic Testing for Aneuploidy)This type of testing is used to screen embryos for numerical chromosomal abnormalities, specifically aneuploidies. Aneuploidy is a condition where there is an abnormal number of chromosomes in an embryo, which can lead to miscarriages or birth defects such as Down syndrome. PGT-A helps identify embryos with the correct number of chromosomes, increasing the likelihood of a successful pregnancy.
Key Market Drivers
Rising Incidence of Genetic Disorders
The rising incidence of genetic disorders is a significant driver for the growth of the global Preimplantation Genetic Testing (PGT) market.
Advancements in Genetic Screening Technologies
Advancements in genetic screening technologies play a crucial role in driving the growth of the global Preimplantation Genetic Testing (PGT) market. These technological innovations enhance the accuracy, efficiency, and accessibility of PGT procedures, making them more appealing and feasible for a wider range of individuals and couples.
Rising demand for IVF
The rising demand for in vitro fertilization (IVF) procedures significantly drives the growth of the global Preimplantation Genetic Testing (PGT) market. IVF and PGT are often integrated to enhance the success rates of fertility treatments and ensure healthier pregnancies.
PGT helps optimize the selection of embryos for transfer, potentially reducing the number of cycles needed and the associated physical, emotional, and financial burdens.
Key Market Challenges
Ethical And Moral Concern
The use of PGT to select for certain traits, such as eye color or intelligence, could lead to discrimination against people who do not have those traits. This is because PGT could make it more likely that people with certain traits will be born, and less likely that people with other traits will be born. This could lead to a society where people are divided into different groups based on their genetic makeup.
Inaccuracies and False Positives/Negatives
Inaccuracies can lead to the selection of embryos that are not free of genetic diseases. This could result in the birth of a child with a genetic disease. False positives can lead to the discarding of embryos that are healthy. This could reduce the chances of a successful pregnancy. False negatives can lead to the implantation of embryos that have genetic diseases. This could result in the birth of a child with a genetic disease.
Limited Access and Awareness
PGT is a relatively new technology, and it is not yet found at in all countries. Even in countries where it is found at, it may not be offered by all IVF clinics. This can make it difficult for people to access PGT, especially those who live in rural areas or who have limited financial resources. Many people are not aware of PGT or its benefits. This can make it difficult for people to make informed decisions about whether or not to use the procedure.
Key Market Trends
Growing Number of Fertility Clinics Offering Preimplantation Genetic Testing (PGT) Services
The global Preimplantation Genetic Testing market, As more fertility clinics offer PGT services, the accessibility of these services to a larger population of prospective parents increases. This trend helps to bring PGT procedures closer to those seeking reproductive assistance, making it easier for individuals or couples to access genetic testing and make informed decisions about their family planning.
Segmental Insights
Procedure
In 2022, the Preimplantation Genetic Testing market was dominated by the Pre-implantation genetic diagnosis (PGD) and is predicted to continue expanding over the coming years. PGD is used to identify specific genetic defects or chromosomal abnormalities in embryos before implantation. It is commonly used by couples who are carriers of genetic disorders and want to ensure that their offspring do not inherit these conditions. PGD helps to prevent the transmission of genetic diseases to future generations. The segment is projected to experience the highest compound annual growth rate (CAGR) from 2023 to 2030.
Product Insight
In 2022, the Preimplantation Genetic Testing market was dominated by reagents and consumables segment and is predicted to continue expanding over the coming years. Reagents and consumables play a crucial role in the success of Preimplantation Genetic Testing (PGT) procedures, and they often dominate the global PGT market in terms of product categories.
Technology Insight
In 2022, the Preimplantation Genetic Testing market was dominated by polymerase chain reaction (PCR) segment and is predicted to continue expanding over the coming years. PCR is one of the most widely used and established technologies in molecular biology and genetics. Its well-established reputation and proven track record contribute to its dominance in PGT.
Application Insight
In 2022, the Preimplantation Genetic Testing market was dominated by aneuploidy screening segment and is predicted to continue expanding over the coming years. Aneuploidies, which involve an abnormal number of chromosomes in embryos, are a common cause of implantation failure, miscarriages, and genetic disorders. A significant portion of couples seeking PGT are primarily concerned with identifying aneuploid embryos to increase the chances of successful pregnancies.
End-Use Industry Insights
In 2022, the Preimplantation Genetic Testing market was dominated by hospital segment and is predicted to continue expanding over the coming years. High patient volume, improving healthcare infrastructure and the availability of both public and private IVF hospitals are a few reasons for the segment’s growth. Most couples who are looking for fertility treatment come to hospitals for additional treatments due to the advanced technology found at in hospitals. Furthermore, the increase in research conducted at hospitals is likely to lead to an increase in testing rates in hospitals. The hospital segment is expected to grow at the fastest CAGR over the next few years.
Regional Insights
The Europe region has established itself as the leader in the Global Preimplantation Genetic Testing Market. Many European countries have well-developed healthcare systems and advanced medical facilities, which facilitate the adoption of advanced genetic testing technologies like PGT.
Recent Developments
- CPMC’s LRDP (also calledthe proposed project) is a multi-pronged strategic plan toMeet Staterequirements for hospital seismic safety (SB 1953). Establish a 20 yearframework and institutional master plan for its four current medical campuses(Sacramento’s Pacific Campus at the corner of Pacific Avenue and BuchananStreet; California at Maple Avenue and California Streets; Davies’ Campus atCastro Avenue and 14th Street; St. Luke’s Campus at Caesars Avenue and ValenciaStreet) Establish a new proposed medical campus (Van Ness Avenue at GearyBoulevard in San Francisco).
- In February 2023, CooperSurgical(COO) has signed a Letter of Intent to Acquire Cook Medical's ReproductiveHealth Business, a Manufacturer of Minimally Invasive Medical Devices with aFocus on the Fertility, Obstetrics and Gynecology Markets. Cooper will pay $875million in cash at closing, USD200 million to be paid in four installments of USD50million. Al White, President and CEO of CooperSurgical, said, "Thisacquisition is a strategic fit for our company. We are expanding ourinternational fertility presence, particularly in Asia-Pacific, and addinghighly synergistic, well-regarded labor and delivery device to our ObGenportfolio. These quality products will seamlessly integrate into our business,supporting CooperSurgical's vision for a world of healthy women, children andfamilies.
- In August 2022, GeneaFertility proudly served as a platinum sponsor for the AJFN’s annual majorfundraising event, which featured a raffle, original live music, immersivemedia, and candid, heartfelt stories. Funds raised support the 44 Jewishfamilies in need of assistance in the process of trying to conceive their dreamchild.
Key Market Players
- California Pacific MedicalCenter (CPMC)
- CombiMatrix Corp
- CooperSurgical, Inc.
- F. Hoffmann-La Roche Ltd.
- Genea Limited
- Genesis Genetics
- Good Start Genetics, Inc.
- IGENOMIX
- Illumina, Inc.
- Invitae Corporation
- Laboratory Corporation ofAmerica Holdings
| By Product | By Application | By End User | By Region |
|
|
|
|
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy